Skip to content
AnalystLens

ConocoPhillips 8-K Report, Financial Results (Aug 7, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed August 7, 2025
Period End
August 7, 2025
Security
COP
In the record · 2016–202610-K1110-Q338-K108

COP filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 108 current reports (8-K) between 2016 and 2026.

  1. Impairment8-K · Jun ’17Jun ’17
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Leadership change8-K · Nov ’22Nov ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed August 7, 2025. Cited figures are marked; the original filing is the authoritative source.

ConocoPhillips reported second-quarter 2025 GAAP earnings of $2.0 billiona, or $1.56 per share, down from $2.3 billion, or $1.98 per share, a year earlier.

Excluding special items, adjusted earnings were $1.8 billionb, or $1.42 per share, versus $1.98 per share in 2Q24. Special items were mainly gains on asset sales. Operating cash flow was $3.5 billion, but excluding a $1.2 billion working capital swing, mostly tax payment timing, cash from operations (CFO) was $4.7 billion.

Realized prices fell 19% year over year to $45.77c per BOE, which more than offset higher production and drove the earnings decline. The quarter's main story is integration and cost execution following the Marathon Oil acquisition. Management reiterated more than $1 billion of run-rate synergies by year-end 2025, plus over $1 billion of one-time benefits, and set a new target of more than $1 billion of additional run-rate cost reductions and margin enhancements by year-end 2026.

Portfolio pruning continued with a $1.3 billiond agreement to sell Anadarko Basin assets, which closes in early 4Q25, bringing the disposition target to $5 billion by year-end 2026. Shareholder returns totaled $2.2 billion in the quarter, including $1.2 billion of buybacks and $1.0 billion of ordinary dividends, and the company declared a $0.78 third-quarter dividend. Outlook is mostly steady: 3Q25 production is guided to 2.33 to 2.37 MMBOED and full-year 2025 to 2.35 to 2.37 MMBOED, with the midpoint unchanged after adjusting for dispositions.

The full-year effective tax rate is now expected in the mid-to-high 30% range, including about a $0.5 billion deferred tax benefit. Ending cash and short-term investments were $5.7 billion. Investors should weigh weaker price realizations and a higher tax rate against the synergy progress and disposal-driven balance sheet support.

Key Highlights

  1. GAAP EPS of $1.56 (2Q25 net income $2.0B) versus $1.98 in 2Q24; adjusted EPS of $1.42 versus $1.98, reflecting lower realized prices and higher DD&A and operating costs.
  2. Realized price of $45.77/BOE, down 19% year over year, the main driver of lower earnings despite higher production of 2,391 MBOED.
  3. Marathon Oil integration complete, with more than $1B of run-rate synergies targeted by year-end 2025 and over $1B of one-time benefits.
  4. New target of more than $1B of incremental run-rate cost reductions and margin enhancements by year-end 2026.
  5. $1.3B Anadarko Basin divestiture expected to close at the beginning of 4Q25; disposition target raised to $5B by year-end 2026.
  6. Shareholder returns of $2.2B in the quarter ($1.2B buybacks, $1.0B dividends); $0.78 per share third-quarter dividend declared.
  7. Full-year 2025 production guidance of 2.35 to 2.37 MMBOED (midpoint unchanged); full-year effective tax rate now in the mid-to-high 30% range.

Frequently Asked Questions

  1. Why did earnings decline year over year despite higher production?

    Production rose to 2,391 MBOED, up 446 MBOED from 2Q24, largely from the Marathon Oil acquisition. However, the total realized price fell 19% to $45.77/BOE, and DD&A and operating costs also increased. Those factors more than offset the volume benefit. Adjusted earnings were $1.8B versus $2.3B a year earlier.

  2. How strong was cash generation in the quarter?

    Reported operating cash flow was $3.5B. Excluding a $1.2B working capital change, primarily timing of tax payments, CFO was $4.7B. The company also received $0.7B from the Ursa and associated asset sales.

  3. What is the status of the Marathon Oil synergy targets?

    ConocoPhillips completed the asset integration and remains on track for more than $1B of run-rate synergies by year-end 2025 and over $1B of one-time benefits. It has also set a new goal of an additional $1B-plus of cost reductions and margin enhancements by year-end 2026.

  4. Will the Anadarko Basin sale and other dispositions affect production and capital returns?

    The $1.3B Anadarko Basin sale is expected to close at the beginning of 4Q25, and the company raised its disposition target to $5B by year-end 2026. Management said the midpoint of full-year production guidance is unchanged even after adjusting for announced and closed dispositions. The company returned $2.2B to shareholders in 2Q25 and declared a $0.78 third-quarter dividend, payable September 2, 2025.